A double-Blind, placebo-controlled, parallel group study to assess the efficacy, and safety of oral frovatriptan in the prevention on menstrually-related migraine (MRM) headaches in a `difficult to treat' population

Trial Profile

A double-Blind, placebo-controlled, parallel group study to assess the efficacy, and safety of oral frovatriptan in the prevention on menstrually-related migraine (MRM) headaches in a `difficult to treat' population

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Apr 2014

At a glance

  • Drugs Frovatriptan (Primary)
  • Indications Menstrual migraine
  • Focus Therapeutic Use
  • Sponsors Endo Pharmaceuticals
  • Most Recent Events

    • 21 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top